This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2011-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2017
Title: Innovations by Takeshi Hamada
Introduction
Takeshi Hamada is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative methods for producing chemical compounds. With a total of 3 patents to his name, Hamada continues to push the boundaries of scientific research and development.
Latest Patents
One of Hamada's latest patents is a method for producing a 1,4-benzoxazine compound. This invention provides an industrially advantageous approach to creating a compound that is useful as a medicine while minimizing safety and health risks. The method involves three key steps: converting the amino group at the 7-position in a compound into a dimesylamino group, coupling a compound with a boronic acid compound, and converting the 7-position in another compound into a monomesylamino group. This innovative process highlights Hamada's commitment to advancing pharmaceutical chemistry.
Career Highlights
Hamada is currently associated with Mitsubishi Tanabe Pharma Corporation, where he applies his expertise in medicinal chemistry. His work at the company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to innovative drug development.
Collaborations
Some of Hamada's notable coworkers include Tomoyuki Okabe and Kaori Tomikawa. Their collaborative efforts have played a crucial role in advancing research and development projects within the company.
Conclusion
Takeshi Hamada's innovative work in the field of medicinal chemistry exemplifies the impact of dedicated inventors on the pharmaceutical industry. His methods for producing valuable chemical compounds continue to pave the way for safer and more effective medicines.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
